Osteoporosis International
A scientific journal focusing on osteoporosis research
Osteoporosis International is a peer-reviewed medical journal dedicated to the field of osteoporosis and related areas of bone health. It serves as a comprehensive resource for researchers, clinicians, and healthcare professionals interested in the latest developments in osteoporosis research, prevention, diagnosis, and treatment.
History[edit | edit source]
Osteoporosis International was established in 1990 and has since become a leading journal in the field of osteoporosis. It is published by Springer Science+Business Media and is the official journal of the International Osteoporosis Foundation and the National Osteoporosis Foundation.
Scope and Content[edit | edit source]
The journal covers a wide range of topics related to osteoporosis, including:
- Epidemiology and pathophysiology of osteoporosis
- Advances in diagnostic techniques
- Prevention strategies
- Pharmacological and non-pharmacological treatment options
- Impact of osteoporosis on quality of life
- Health economics and policy related to osteoporosis
Editorial Process[edit | edit source]
Osteoporosis International employs a rigorous peer-review process to ensure the quality and relevance of its published articles. The editorial board consists of experts in the field who evaluate submissions based on scientific merit, originality, and contribution to the field.
Publication Frequency[edit | edit source]
The journal is published monthly, providing a steady stream of new research findings and reviews to its readership.
Access and Availability[edit | edit source]
Osteoporosis International is available both in print and online, allowing for wide accessibility to its content. Subscribers can access the journal through institutional or personal subscriptions, and individual articles can be purchased online.
Related Pages[edit | edit source]
- Osteoporosis
- Bone density
- Fracture risk assessment
- International Osteoporosis Foundation
- National Osteoporosis Foundation
Images[edit | edit source]
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
